MX378754B - Métodos y reactivos para la prevención y/o el tratamiento de infecciones. - Google Patents

Métodos y reactivos para la prevención y/o el tratamiento de infecciones.

Info

Publication number
MX378754B
MX378754B MX2017002385A MX2017002385A MX378754B MX 378754 B MX378754 B MX 378754B MX 2017002385 A MX2017002385 A MX 2017002385A MX 2017002385 A MX2017002385 A MX 2017002385A MX 378754 B MX378754 B MX 378754B
Authority
MX
Mexico
Prior art keywords
prevention
treatment
infections
reagents
methods
Prior art date
Application number
MX2017002385A
Other languages
English (en)
Other versions
MX2017002385A (es
Inventor
Vallés Cristina Costa
Gil Daniel Bello
Cruz Magdiel Pérez
Mendiluce Rafael Mañez
Original Assignee
Inst Dinvestigacio Biomedica De Bellvitge Idibell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Dinvestigacio Biomedica De Bellvitge Idibell filed Critical Inst Dinvestigacio Biomedica De Bellvitge Idibell
Publication of MX2017002385A publication Critical patent/MX2017002385A/es
Publication of MX378754B publication Critical patent/MX378754B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere al campo de agentes terapéuticos y, más en particular, a agentes y composiciones para la prevención y/o el tratamiento de infección causada por bacterias del tracto gastrointestinal en un sujeto, basándose dichos agentes y composiciones en agentes que comprenden un resto de a-galactosilo terminal.
MX2017002385A 2014-08-22 2015-08-24 Métodos y reactivos para la prevención y/o el tratamiento de infecciones. MX378754B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14382324.3A EP2987503A1 (en) 2014-08-22 2014-08-22 Methods and reagents for prevention and/or treatment of infection
PCT/EP2015/069334 WO2016026981A1 (en) 2014-08-22 2015-08-24 Methods and reagents for prevention and/or treatment of infection

Publications (2)

Publication Number Publication Date
MX2017002385A MX2017002385A (es) 2017-06-30
MX378754B true MX378754B (es) 2025-03-10

Family

ID=51485539

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017002385A MX378754B (es) 2014-08-22 2015-08-24 Métodos y reactivos para la prevención y/o el tratamiento de infecciones.

Country Status (13)

Country Link
US (1) US20260224612A1 (es)
EP (2) EP2987503A1 (es)
JP (1) JP6612346B2 (es)
KR (1) KR102492850B1 (es)
CN (1) CN107073020B (es)
AU (1) AU2015305108B2 (es)
CA (1) CA2958600C (es)
ES (1) ES2759565T3 (es)
MX (1) MX378754B (es)
PL (1) PL3183003T3 (es)
RU (1) RU2698099C2 (es)
SG (1) SG11201806985WA (es)
WO (1) WO2016026981A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019094952A1 (en) 2017-11-10 2019-05-16 The Johns Hopkins University Dendrimer delivery system and methods of use thereof
CN108646029B (zh) * 2018-05-14 2021-07-02 中国食品药品检定研究院 人抗-Gal-IgG抗体检测试剂盒及其制备方法和用途
EP3832762B1 (en) * 2018-07-31 2025-09-24 Sumitomo Metal Mining Co., Ltd. Positive electrode active material for lithium ion secondary battery, method for producing positive electrode active material for lithium ion secondary battery, and lithium ion secondary battery
US20230338554A1 (en) * 2020-09-08 2023-10-26 The Johns Hopkins University Galactosylated dendrimers for targeted intracellular delivery to hepatocytes
EP3964235A1 (en) * 2020-09-08 2022-03-09 RemAb Therapeutics SL Glycoconjugates and medical uses thereof
WO2023138211A1 (zh) * 2022-01-21 2023-07-27 苏州万维生命科学技术有限公司 星型β-抗菌糖肽、其制备方法及应用
CN116515102B (zh) * 2022-01-21 2025-04-18 苏州万维生命科学技术有限公司 星型β-抗菌糖肽、其制备方法及应用
US20240123420A1 (en) * 2022-10-12 2024-04-18 Kelly Nicholson Furnace for endothermic processes
WO2024082390A1 (zh) * 2022-10-18 2024-04-25 天津德祥生物技术股份有限公司 血型抗原三糖偶联物在血型抗体检测中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0089940A1 (en) * 1982-03-23 1983-09-28 BioCarp AB Compositions for therapeutic or diagnostic use containing oligosaccharides
US5262165A (en) 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
US6010715A (en) 1992-04-01 2000-01-04 Bertek, Inc. Transdermal patch incorporating a polymer film incorporated with an active agent
AUPM623994A0 (en) * 1994-06-15 1994-07-07 Biomolecular Research Institute Limited Antiviral dendrimers
PL181582B1 (pl) 1995-06-07 2001-08-31 Ortho Mcneil Pharm Inc Plaster na skóre do zapobiegania owulacji u kobiety oraz plaster na skóre do przeprowadzania hormonalnej terapii substytucyjnej PL PL PL PL PL PL PL PL
DE69835201T2 (de) 1997-04-18 2007-06-14 Novartis Ag Neoglycoproteine
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
DE69927369T2 (de) * 1998-04-15 2006-06-22 Mayo Foundation For Medical Education And Research, Rochester Hemmung xenoreaktiver antikörper
CA2396966A1 (en) * 2000-01-13 2001-07-19 John Papageorgiou Methods for synthesis of .alpha.-d-gal (1.fwdarw.3) gal-containing oligosaccharides
CN1747970A (zh) * 2003-02-06 2006-03-15 三肽公司 抗原/抗体或配体/受体糖基化的特异性交换剂
AU2003901008A0 (en) 2003-03-04 2003-03-20 Anadis Ltd Composition for the treatment and prevention of bacterial infections
US7915235B2 (en) * 2006-03-20 2011-03-29 Brian Dieckgraefe High affinity ligands bind to clostridium difficile toxin A
US8361441B2 (en) 2008-03-11 2013-01-29 Taipei Medical University Detection and therapy of bacterial infection caused by Enterobacteriaceae
US7928077B2 (en) * 2008-07-11 2011-04-19 Academia Sinica Alpha-galactosyl ceramide analogs and their use as immunotherapies

Also Published As

Publication number Publication date
KR20170043556A (ko) 2017-04-21
AU2015305108A1 (en) 2017-04-06
CA2958600C (en) 2023-01-10
US20260224612A1 (en) 2026-08-06
WO2016026981A1 (en) 2016-02-25
EP3183003B1 (en) 2019-07-31
PL3183003T3 (pl) 2020-03-31
ES2759565T3 (es) 2020-05-11
RU2698099C2 (ru) 2019-08-22
JP2017525763A (ja) 2017-09-07
EP3183003A1 (en) 2017-06-28
AU2015305108B2 (en) 2021-03-18
RU2017108569A (ru) 2018-09-24
MX2017002385A (es) 2017-06-30
CN107073020B (zh) 2019-12-10
KR102492850B1 (ko) 2023-01-26
RU2017108569A3 (es) 2019-03-13
SG11201806985WA (en) 2018-09-27
JP6612346B2 (ja) 2019-11-27
CN107073020A (zh) 2017-08-18
EP2987503A1 (en) 2016-02-24
CA2958600A1 (en) 2016-02-25

Similar Documents

Publication Publication Date Title
CY1122184T1 (el) Συνθεσεις περιλαμβανουσες βακτηριακα στελεχη
CY1121766T1 (el) Συνθεσεις που περιεχουν βακτηριακο στελεχος toy blautia hydrogenotrophica για χρηση στην θεραπεια βακτηριακων λοιμωξεων του γαστρεντερικου αγωγου
CY1121473T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
EA201691534A1 (ru) Лечение устойчивых угрей
DK3804737T3 (da) Sammensætninger omfattende bakteriestammer
PH12016502436A1 (en) Anti-infective compounds
EA201890051A1 (ru) Композиции, содержащие бактериальные штаммы
EA201891199A1 (ru) Композиции, содержащие бактериальные штаммы
EA201891202A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890047A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890048A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890049A1 (ru) Композиции, содержащие бактериальные штаммы
MX386935B (es) Profármacos de fumaratos y su uso en el tratamiento de diferentes enfermedades.
SI3785717T1 (sl) Postopki za zdravljenje okužb s Coronaviridae
EA201790266A1 (ru) Индолы для применения при инфекции, вызванной вирусом гриппа
EA201691766A1 (ru) Органические соединения, являющиеся монобактамами, для лечения бактериальных инфекций
EP3331547A4 (en) COMPOSITIONS WITH PERMEATION PROMOTERS FOR ACTIVE INJECTION
PH12017500393A1 (en) Pyrrolopyrimidines for use in influenza virus infection
EA201790273A1 (ru) Флагеллиновые композиции и их применение
MX2017002385A (es) Metodos y reactivos para la prevencion y/o el tratamiento de infecciones.
MX2021000189A (es) Compuestos heterociclicos que contienen bencilamina y composiciones utiles contra infeccion por micobacterias.
MX2017016401A (es) Composiciones inmunogenas.
DK3600363T3 (da) Sammensætninger omfattende bakteriestammer
PH12016501988A1 (en) Antibacterial compounds
DK3638271T3 (da) Sammensætninger omfattende bakteriestammer